Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

Investigational Site Number 056002, Leuven

Investigational Site Number 840010, Albany

Investigational Site Number 840021, Pittsburgh

Investigational Site Number 380002, Genova

Investigational Site Number 840005, Norfolk

Investigational Site Number 840055, Tucker

Investigational Site Number 840063, Augusta

Investigational Site Number 840027, Jacksonville

Investigational Site Number 840013, Birmingham

Investigational Site Number 840002, Jackson

Investigational Site Number 840043, Cleveland

Investigational Site Number 724001, Valencia

Investigational Site Number 840012, Indianapolis

Investigational Site Number 840001, Detroit

Investigational Site Number 840025, Sioux City

Investigational Site Number 840039, Maywood

Investigational Site Number 840059, St Louis

Investigational Site Number 840004, St Louis

Investigational Site Number 840019, Plano

Investigational Site Number 840007, Austin

Investigational Site Number 840003, El Paso

Investigational Site Number 840008, Denver

Investigational Site Number 840022, Las Vegas

Investigational Site Number 840046, Vallejo

Investigational Site Number 840009, Vancouver

Investigational Site Number 840033, Santa Maria

Investigational Site Number 840030, Boston

Investigational Site Number 840006, Minneapolis

Investigational Site Number 840017, Voorhees Township

Investigational Site Number 840015, Charlotte

Investigational Site Number 840060, Cincinnati

Investigational Site Number 840028, Memphis